PineBridge Investments, L.P. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
PineBridge Investments, L.P. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$743,000
-42.8%
31,298
-33.8%
0.01%
-47.6%
Q3 2019$1,299,000
-9.1%
47,267
+9.5%
0.02%
-8.7%
Q2 2019$1,429,000
+204.7%
43,180
+222.6%
0.02%
+130.0%
Q1 2019$469,000
+8.1%
13,385
+2.3%
0.01%0.0%
Q4 2018$434,000
-21.4%
13,082
+19.3%
0.01%0.0%
Q3 2018$552,000
+8.4%
10,969
+29.1%
0.01%
-16.7%
Q2 2018$509,000
+24.1%
8,496
-5.0%
0.01%
+20.0%
Q1 2018$410,000
-46.4%
8,942
-53.4%
0.01%
-50.0%
Q4 2017$765,000
+203.6%
19,193
+205.0%
0.02%
+233.3%
Q3 2017$252,000
-11.6%
6,292
-5.0%
0.01%
-14.3%
Q2 2017$285,000
+39.0%
6,624
+1.3%
0.01%
+40.0%
Q1 2017$205,000
+28.9%
6,538
+3.9%
0.01%0.0%
Q4 2016$159,000
+2.6%
6,2950.0%0.01%
-28.6%
Q3 2016$155,000
+74.2%
6,295
+43.5%
0.01%
+40.0%
Q2 2016$89,000
+45.9%
4,388
+9.0%
0.01%
+66.7%
Q1 2016$61,000
-1.6%
4,024
-12.4%
0.00%0.0%
Q4 2015$62,000
+21.6%
4,596
+28.0%
0.00%
+50.0%
Q3 2015$51,000
-8.9%
3,591
+10.2%
0.00%0.0%
Q2 2015$56,0003,2590.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders